β-alanine supplementation in adults with overweight and obesity: a randomized controlled feasibility trial.
- 2025-01-12
- RCT · n = 27
- Obesity (Silver Spring, Md.) 33(2)
- Joseph J Matthews
- Jade V Creighton
- James Donaldson
- Paul A Swinton
- Ioannis Kyrou
- Srikanth Bellary
- Iskandar Idris
- Lívia Santos
- Mark D Turner
- Craig L Doig
- Kirsty J Elliott-Sale
- Craig Sale
- PubMed: 39800667
- DOI: 10.1002/oby.24204
- High evidence
- Clinical
the probability that β-alanine supplementation affected cardiometabolic, cardiovascular, or clinical biochemical outcomes was low
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 4.8 g/day